In sporadic CRC, the most common form, loss of p53 function is a critical step in the adenoma-to-adenocarcinoma transition; p53 mutations are detected in 55–60% of non-hypermutated and ~20% of hypermutated CRC [2,3]. Here, TP53 is linked to adenocarcinoma.